GDRXGoodRx Holdings, Inc.
Is it safe?
Nothing alarming, nothing pristine: comfortable debt (A) and big price swings.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Large price swings, high volatility. Worst drawdown -97% · now 27% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can GDRX take a bad year?
GoodRx Holdings, Inc. carries $190M of net debt at 1.16× EBITDA: a load its earnings can carry.
Net debt · as at Q2 2026 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.16×
Net debt / EBITDA · 1.26× a year ago · the load is coming down
- Interest cover
- 1.84×
Interest cover · operating profit barely covers the interest bill
- Annualised volatility
- 65%
Annualised volatility · three times the market's own swing
Details›
- Total debtQ2 2026
- $487M
- Cash and short-term investments
- $296M
- Net debt
- $190M
- EBITDA, trailing twelve months
- $164M
- Operating profit, trailing twelve months
- $75M
- Debt / equity
- 0.75×
- Total debt / EBITDA
- 2.98×
- Annualised volatilitytwo years of daily moves
- 65%
- Worst drawdown on file
- −97%
- Below its 52-week high
- 27%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Health Information Services
Ranks #5 of 20 by RyuScore